WWP2 overexpression inhibits the antitumor effects of doxorubicin in hepatocellular carcinoma

Qin, Y; Wang, CJ; Ye, HL; Ye, GX; Wang, S; Pan, DB; Wang, J; Shen, HJ; Xu, SQ

Xu, SQ (通讯作者),Wenzhou Med Univ, Affiliated Hosp 1, Affiliated Hosp 6, People Hosp LiShui,Dept Hepatobil Surg, 15th Publ St, Lishui 323000, Peoples R China.

CELL BIOLOGY INTERNATIONAL, 2022; 46 (10): 1682

Abstract

Hepatocellular carcinoma (HCC) is a common liver cancer that accounts for 90% of cases. Doxorubicin exhibits a broad spectrum of antitumor activity an......

Full Text Link